Only 2-5% of patients receiving TNF inhibitors for other conditions, such as rheumatoid arthritis or inflammatory bowel disease, develop paradoxical psoriasis with generalized pustular psoriasis being among the least common presentations [3]. The gene discussed is TNF; the disease is psoriasis.